Senior Advisor, Good Energies

Howard Berke is a Senior Advisor to Good Energies, a private investment firm in solar photovoltaic companies and wind developers. Good Energies contributes as a strategic investor to the ongoing energy transition process through its long-term investments and its support of development initiatives in the field of clean energy technologies. Good Energies is a member of COFRA Holding AG, Zug/Switzerland and is represented through offices in London, New York, Toronto, Washington DC and Zug (www.goodenergies.com)
Mr. Berke has nearly 30 years of hands-on management experience launching, building and leading both public and private technology companies. This includes over 20 years of general management with full P&L responsibility for eight start-up companies and ten years of business development and marketing focusing on emerging technologies. Howard Berke is currently chairman and co-founder of Konarka Technologies, an innovator in development and commercialization of Power Plastic TM, a material that converts light to energy.
He has founded or co-founded 13 start-up companies and has initiated and completed numerous corporate acquisitions, mergers and R&D joint ventures in the U.S., Europe and Asia. He advises start-up companies and entrepreneurs in a wide range of fields including medical devices, biotech informatics, software, networking, telecom and energy technology.
In addition to serving as delegate to the World Economic Forum's Technology Pioneers, he sits on the board of directors for ACORE, has helped to found and organize the New England Clean Energy Council and has guest lectured on entrepreneurship at Yale, Harvard, MIT and elsewhere throughout the world.
Berke received a Master of Business Administration (MBA) from the University of Chicago and a Bachelor of Arts (BA) from Yale University. His academic training includes finance, accounting, operations research, corporate law, architecture and physics.

Josh Wolfe
Founding Partner & Managing Director,
Lux Capital Management

Josh Wolfe is a co-founder and Managing Partner of Lux Capital focusing on the firms' venture investments in physical & life sciences. He has led Lux's direct investments in Nanosys, Molecular Imprints, Cambrios, Crystal IS, Silicon Clocks and Magen. Josh sits on the Board of Crystal IS, Silicon Clocks, Lux Research (a research and advisory firm serving Fortune 100, government and buy-side clients) and Angstrom Publishing (a media joint venture with Forbes, Inc.).
Before forming Lux Capital, he worked in Salomon Smith Barney's Investment Banking group , Merrill Lynch 's Financial Futures Options/Government Strategy Group and Prudential Securities Municipal Finance department. Josh serves on Merrill Lynch's TechBrains Advisory Board. Josh was a Westinghouse semi-finalist at 15 and conducted and published cutting edge HIV/AIDS and immunopathology research. He has been published in Nature Biotechnology, Cell Vision and The Journal of Leukocyte Biology, leading medical/immunology journals. Josh graduated with distinction from Cornell University with a B.S. in Economics and Finance.
Josh has a column at Forbes magazine, is the author of the 500 pg book "The Nanotech Report" and Editor of Forbes' fastest growing monthly investment publication, the "Forbes/Wolfe Emerging Tech Report." His public policy work includes co-founding the NanoBusiness Alliance--the industry organization for nanotechnology and joined President Bush in the Oval Office during the historic signing of the 21st Century Nanotech R &D Act in December 2003. He has been an invited kenyote or guest lecturer at over 300 events including Harvard Business School, Yale, Columbia, Cornell, Wharton, the National Science Foundation, FDA and government officials in France, Spain, Germany, Canada, Brazil, UK and Singapore. Red Herring has called him "Mr. Nano". Steve Forbes has called Lux a "powerhouse of nanotech brainpower" and Josh Wolfe "America's Leading Authority on Nanotechnology". Josh was honored by Crain's magazine as one of their "40 under 40" and has appeared in Business Week, The New York Times, Forbes, The Wall Street Journal, Wired, CBS News, The New York Post and has been a regular guest on CNBC's Kudlow & Cramer, Bullseye and Closing Bell.
He is a founding member of junior boards for The East Harlem School at Exodus House, the Hospital for Special Surgery, Coney Island Prep and the Cancer Research Institute. Josh is a native of Brooklyn, New York.